Results 1 to 10 of about 5,432 (115)

Explaining Uncertain Hepatoprotective Effects: When Silibinin Co-Administered with Other Drugs [PDF]

open access: yesMedeniyet Medical Journal
Objective: This study investigated the herb-drug interaction between silibinin and carbamazepine (CBZ) and the potential risk of adverse drug reactions (ADR) when silibinin is co-administered with other drugs.
Dong Pu   +5 more
doaj   +2 more sources

Enhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in Combination with Ciprofloxacin and HepG2 cancer cells [PDF]

open access: yesScientific Reports
Silibinin, a major bioactive compound extracted from Silybum marianum, possesses notable antioxidant, antitumor, hepatoprotective, and antibacterial activities. However, its poor solubility limits its clinical applications.
Sanaz Borji   +4 more
doaj   +2 more sources

Silibinin attenuates ferroptosis in acute kidney injury by targeting FTH1

open access: yesRedox Biology
Acute kidney injury (AKI) is primarily caused by renal ischemia-reperfusion injury (IRI), which is one of the most prevalent triggers. Currently, preventive and therapeutic measures remain limited.
Yijian Deng   +16 more
exaly   +3 more sources

Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin [PDF]

open access: yesBioImpacts, 2020
Introduction: Silibinin is a naturally occurring compound with known positive impacts on prevention and treatment of many types of human illnesses in general and cancer in particular.
Ashkan Hassankhani Rad   +5 more
doaj   +1 more source

Silibinin Inhibits Cell Ferroptosis and Ferroptosis-Related Tissue Injuries

open access: yesAntioxidants, 2023
Ferroptosis is involved in various tissue injuries including neurodegeneration, ischemia-reperfusion injury, and acute liver injury. Ferroptosis inhibitors exhibit promising clinical potential in the treatment of various diseases.
Wentao Duan   +11 more
doaj   +1 more source

Effect of Silibinin in Lowering the Intraocular Pressure in Normotensive Rabbits: Interaction with Betaxolol

open access: yesIraqi Journal of Pharmaceutical Sciences, 2017
Previous reports demonstrated the effectiveness of silibinin hemisuccinate as a potential intraocular pressure-lowering agent. The exact mechanism by which silibinin exerted this effect has not yet been documented, but might suggested to interfere with ...
Saad A. Hussain   +3 more
doaj   +3 more sources

Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis [PDF]

open access: yesBioImpacts, 2022
Introduction: Malignant breast cancer (BC) frequently contains a rare population of cells called cancer stem cells which underlie tumor relapse and metastasis, and targeting these cells may improve treatment options and outcomes for patients with BC. The
Javad Firouzi   +9 more
doaj   +1 more source

Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner. [PDF]

open access: yesPLoS ONE, 2016
The objective of this study was to evaluate the effects of silibinin on cell proliferation in platelet-derived growth factor (PDGF)-treated human Tenon's fibroblasts (HTFs).
Yi-Hao Chen   +5 more
doaj   +1 more source

Amelioration of amyloid beta (Aβ1-40) neurotoxicity by administration of silibinin; a behavioral and biochemical assessment [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2023
Objective(s): Alzheimer’s disease (AD), the most common cause of dementia, is one of the leading causes of morbidity and death in the world. Currently, treatment mostly used to slow down the disease progression.
Tahereh Alihosseini   +4 more
doaj   +1 more source

Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma

open access: yesFrontiers in Pharmacology, 2021
Background: Effective anticancer therapy can be achieved by identifying novel tumor-specific drug targets and screening of new drugs. Recently, TMEM16A has been identified to be overexpressed in lung adenocarcinoma, and inhibitors of TMEM16A showed ...
Shuai Guo   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy